Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clonal identification in acute lymphoblastic leukemia.

A H Goldstone, B A McVerry, G Janossy

    Blood
    |May 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    In acute lymphoblastic leukemia, distinct drug-sensitive and drug-resistant blast cell types emerged. Resistant subclones with new chromosomal abnormalities drove disease progression, highlighting their role in relapse.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial.

    Bone marrow transplantation·2021
    Same author

    The evolving role of chemotherapy and hematopoietic cell transplants in Ph-positive acute lymphoblastic leukemia in adults.

    Bone marrow transplantation·2017
    Same author

    Autologous Bone-Marrow Transplantation in Acute Lymphoblastic Leukaemia: 1980-89.

    Leukemia & lymphoma·2016
    Same author

    Systemic Irradiation Therapy of Myelomatosis-The Therapeutic Implications of Technique.

    Leukemia & lymphoma·2016
    Same author

    Scabies Infestation following Autologous Bone Marrow Transplantation.

    Leukemia & lymphoma·2016
    Same author

    Recombinant Alpha 2A Interferon-An Effective Maintenance Agent in Essential Thrombocythaemia.

    Leukemia & lymphoma·2016
    Same journal

    Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

    Blood·2026
    Same journal

    Identifying steroid-refractory aGVHD before it happens.

    Blood·2026
    Same journal

    ELISA-negative HIT: antibody recognition and relevance.

    Blood·2026
    Same journal

    EBV and immunodeficiency: the odd couple drawn to the brain.

    Blood·2026
    Same journal

    A bone to pick with ferric carboxymaltose.

    Blood·2026
    Same journal

    A step toward streamlining HIT diagnosis.

    Blood·2026
    See all related articles

    Area of Science:

    • Hematology
    • Oncology
    • Cell Biology

    Background:

    • Acute lymphoblastic leukemia (ALL) is a heterogeneous hematologic malignancy.
    • Understanding the mechanisms of chemotherapy resistance is crucial for improving patient outcomes.
    • The emergence of drug-resistant subclones can lead to disease relapse.